# Trade Mark Journal No.2026/025 19 June 2026

## UK00004398173 5 June 2026 (9,35,42)

Mark 1

Mark 2

Class 9
  Software; application software; computer software; computer software platforms; artificial intelligence software; artificial intelligence software platforms; artificial intelligence software for drug discovery; artificial intelligence software and software platforms for conducting market intelligence research and analysis in the fields of life sciences, pharmaceuticals and medicines; artificial intelligence software and software platforms for research, data analysis and data integration in the fields of life sciences, pharmaceuticals and medicines; artificial intelligence software and software platforms for supporting decision-making in drug discovery, target identification and biomedical research; artificial intelligence software and software platforms for providing scientific, commercial and financial insights, predictions and recommendations; data analytics software; business intelligence software for use in the fields of life sciences, pharmaceuticals and medicines; artificial intelligence software and software platforms for use in the fields of life sciences, pharmaceuticals and medicines; artificial intelligence software and software platforms for pattern discovery, contextual prediction, predictive analytics and predictive modelling in the fields of life sciences, pharmaceuticals and medicines; artificial intelligence software and software platforms for supporting decision-making in the fields of life sciences, pharmaceuticals and medicines, utilising pattern discovery, contextual prediction, predictive analytics and predictive modelling; artificial intelligence software and software platforms for the collection, storage, aggregation, integration, management, processing, analysis and retrieval of scientific, clinical, medical and business data; artificial intelligence software and software platforms for the display, presentation, analysis, processing and organisation of business intelligence data and information relating to life sciences, pharmaceuticals and medicines; artificial intelligence software and software platforms for end-to-end operations automation, cloud automation, workflow automation, anomaly detection, deployment automation and operations automation.
Class 35
  Business management consultancy for the analysis and implementation of strategy plans and commercial decisions, including such services based on data analytics and artificial intelligence; business research and intelligence services in the fields of life sciences, pharmaceuticals and medicines; business data analysis services; provision of business intelligence insights, predictions and recommendations in the fields of life sciences, pharmaceuticals and medicines; business information services relating to data analysis; commercial data analysis and evaluation services; information, advisory, and consultation services relating to the aforesaid.
Class 42
  Scientific and technological services; design and development of software; information technology services; computer services; software as a service (SaaS); platform as a service (PaaS); artificial intelligence as a service (AIaaS); application service provider services; application service provider (ASP) services, namely, hosting software applications and platforms; hosting of databases, applications, computer sites and platforms on the internet; cloud storage services for electronic data; medical, biomedical and biotechnology research; drug discovery services; providing non-downloadable software; providing non-downloadable application software; providing non-downloadable computer software; providing non-downloadable computer software for research and for data analysis; providing non-downloadable computer software platforms; providing non-downloadable artificial intelligence software; providing non-downloadable artificial intelligence software platforms; providing non-downloadable artificial intelligence software and software platforms for research and for data analysis; providing non-downloadable business intelligence software for use in the fields of life sciences, pharmaceuticals and medicines; providing non-downloadable artificial intelligence software for drug discovery; providing non-downloadable artificial intelligence software and software platforms for conducting market intelligence research and analysis in the fields of life sciences, pharmaceuticals and medicines; providing non-downloadable artificial intelligence software and software platforms for research, data analysis and data integration in the fields of life sciences, pharmaceuticals and medicines; providing non-downloadable artificial intelligence software and software platforms for supporting decision-making in drug discovery, target identification and biomedical research; providing non-downloadable artificial intelligence software and software platforms for providing scientific, commercial and financial insights, predictions and recommendations; providing non-downloadable artificial intelligence software and software platforms for use in the fields of life sciences, pharmaceuticals and medicines; providing non-downloadable artificial intelligence software and software platforms for pattern discovery, contextual prediction, predictive analytics and predictive modelling in the fields of life sciences, pharmaceuticals and medicines; providing non-downloadable artificial intelligence software and software platforms for supporting decision-making in the fields of life sciences, pharmaceuticals and medicines, utilising pattern discovery, contextual prediction, predictive analytics and predictive modelling; providing non-downloadable artificial intelligence software and software platforms for the collection, storage, aggregation, integration, management, processing, analysis and retrieval of scientific, clinical, medical and business data; providing non-downloadable artificial intelligence software and software platforms for the display, presentation, analysis, processing and organisation of business intelligence data and information relating to life sciences, pharmaceuticals and medicines; providing non-downloadable artificial intelligence software and software platforms for end-to-end operations automation, cloud automation, workflow automation, anomaly detection, deployment automation and operations automation; information, advisory, and consultation services relating to the aforesaid.

BenevolentAI Limited

Representative: Boult Wade Tennant LLP